Ohcanbohtosat - Janku, Filip

Bringing target-matched PI3King from the bench to the clinic Dahkki Janku, Filip

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Tumor heterogeneity in the clinic: is it a real problem? Dahkki Janku, Filip

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Deciding site of biopsy at metastatic relapse: reply Dahkki Janku, Filip

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Liquid Biopsies Using Plasma Exosomal Nucleic Acids Dahkki Möhrmann, Lino, Janku, Filip

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives Dahkki Bupathi, Manojkumar, Kaseb, Ahmed, Janku, Filip

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Targeted Therapies for Advanced Ewing Sarcoma Family of Tumours Dahkki Jiang, Yunyun, Ludwig, Joseph, Janku, Filip

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet? Dahkki Polivka, Jiri, Pesta, Martin, Janku, Filip

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Successful Treatment of Castleman’s Disease with Interleukin-1 Receptor Antagonist (Anakinra) Dahkki El-Osta, Hazem, Janku, Filip, Kurzrock, Razelle

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Signed in Blood: Circulating Tumor DNA in Cancer Diagnosis, Treatment and Screening Dahkki Adashek, Jacob J., Janku, Filip, Kurzrock, Razelle

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

A Tale of Two Histiocytic Disorders Dahkki Janku, Filip, Munoz, Javier, Subbiah, Vivek, Kurzrock, Razelle

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Castleman’s disease and sarcoidosis, a rare association resulting in a “mixed” response: a case report Dahkki Mohammed, Anwarullah, Janku, Filip, Qi, Ming, Kurzrock, Razelle

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

A kinase-independent biological activity for insulin growth factor-1 receptor (IGF-1R): Implications for Inhibition of the IGF-1R signal Dahkki Janku, Filip, Huang, Helen J., Angelo, Laura S., Kurzrock, Razelle

Viečča ollesdeavstta Viečča ollesdeavstta

Bevacizumab-Based Treatment in Colorectal Cancer with a NRAS Q61K Mutation Dahkki Janku, Filip, Wheler, Jennifer J., Hong, David S., Kurzrock, Razelle

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

STAT3 Inhibitors: Finding a Home in Lymphoma and Leukemia Dahkki Munoz, Javier, Dhillon, Navjot, Janku, Filip, Watowich, Stephanie S., Hong, David S.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing Dahkki Janku, Filip, Kaseb, Ahmed O., Tsimberidou, Apostolia M., Wolff, Robert A., Kurzrock, Razelle

Viečča ollesdeavstta Viečča ollesdeavstta

Non-Small Cell Lung Cancer with HER2 Exon 20 Mutation: Regression with Dual HER2 Inhibition and Anti-VEGF Combination Treatment Dahkki Falchook, Gerald S., Janku, Filip, Tsao, Anne S., Bastida, Christel C., Stewart, David J., Kurzrock, Razelle

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Next generation sequencing of carcinoma of unknown primary reveals novel combinatorial strategies in a heterogeneous mutational landscape Dahkki Subbiah, Ishwaria M., Tsimberidou, Apostolia, Subbiah, Vivek, Janku, Filip, Roy-Chowdhuri, Sinchita, Hong, David S.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

A novel immunomodulatory and molecularly targeted strategy for refractory Hodgkin's lymphoma Dahkki Subbiah, Vivek, Brown, Robert E., McGuire, Mary F., Buryanek, Jamie, Janku, Filip, Younes, Anas, Hong, David

Viečča ollesdeavstta Viečča ollesdeavstta

Multiple gene aberrations and breast cancer: lessons from super-responders Dahkki Wheler, Jennifer J., Atkins, Johnique T., Janku, Filip, Moulder, Stacy L., Yelensky, Roman, Stephens, Philip J., Kurzrock, Razelle

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Challenges and perspective of drug repurposing strategies in early phase clinical trials Dahkki Kato, Shumei, Moulder, Stacy L., Ueno, Naoto T., Wheler, Jennifer J., Meric-Bernstam, Funda, Kurzrock, Razelle, Janku, Filip

Viečča ollesdeavstta Viečča ollesdeavstta